Avalon GloboCare Corp. is a commercial-stage company engaged in developing and delivering precision diagnostic consumer products and the advancement of intellectual property in cellular therapy. The Company operates in two reportable business segments: the real property operating segment and the laboratory testing services segment. Its laboratory services offer a test menu that satisfies the clients' testing needs, from general bloodwork to anatomic pathology, urine toxicology, pharmacogenomics (PGx) testing and more, and it is a one-stop-shop for clinical testing. The Company is currently marketing the KetoAir breathalyzer device and plans to develop additional diagnostic uses of the breathalyzer technology. The KetoAir breathalyzer is a handheld device that allows the user to detect acetone levels in exhaled breath. The acetone level is in concentration units part-per-million (ppm) such that the user knows the real-time ketosis status.
äŒæ¥ã³ãŒãALBT
äŒç€ŸåAvalon Globocare Corp
äžå Žæ¥Feb 22, 2016
æé«çµå¶è²¬ä»»è
ãCEOãJin (David)
åŸæ¥å¡æ°5
蚌åžçš®é¡Ordinary Share
æ±ºç®ææ«Feb 22
æ¬ç€Ÿæåšå°4400 Route 9
éœåžFREEHOLD
蚌åžååŒæNASDAQ OMX - NASDAQ BASIC
åœUnited States of America
éµäŸ¿çªå·07728
é»è©±çªå·17327804400
ãŠã§ããµã€ãhttps://www.avalon-globocare.com/
äŒæ¥ã³ãŒãALBT
äžå Žæ¥Feb 22, 2016
æé«çµå¶è²¬ä»»è
ãCEOãJin (David)